Addiction News and Research

RSS

KFF Health News' 'What the Health?': A colorful cast could lead key health agencies

President-elect Donald Trump has continued naming out-of-the-box choices to lead key federal health agencies.

5 Dec 2024

Discovery of leptin-responsive neurons offers new hope for obesity treatment

Obesity affects a staggering 40 percent of adults and 20 percent of children in the United States. While some new popular therapies are helping to tackle the epidemic of obesity, there is still so much that researchers do not understand about the brain-body connection that regulates appetite.

5 Dec 2024

Dual use of vapes and cigarettes hinders smoking cessation

People who use both vapes and cigarettes are less likely to quit compared to people who only smoke or only vape, according to a study published today (Wednesday) in ERJ Open Research.

3 Dec 2024

Baycrest study discovers role of thalamus in post-stroke recovery

A recent study by Baycrest reveals that an area of the brain distinct from the stroke lesion may play a significant role in causing the life-altering symptoms survivors are often left with, which can include severe challenges with speech, mobility and cognition.

3 Dec 2024

California falling short of enrollment goal as mental health courts roll out statewide

California's new initiative to compel treatment for some of the state's most severely mentally ill residents — many of whom are living on the streets — is falling short of its initial objectives.

3 Dec 2024

Boosting endocannabinoids could reduce opioid addiction risk

Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs' ability to relieve pain, according to Weill Cornell Medicine investigators working with researchers from The Center for Youth Mental Health at NewYork-Presbyterian.

2 Dec 2024

Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication

Researchers evaluate changes in alcohol use after initiating antiobesity medication.

29 Nov 2024

Telemedicine and peer support show promise in treating hepatitis C in rural areas

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug use.

27 Nov 2024

IQWiG evaluates smoking cessation drugs for severe tobacco dependence treatment

By law, smokers with severe tobacco dependence are entitled to receive one-off drug therapy for smoking cessation as part of evidence-based programmes reimbursed by the German statutory health insurance (SHI).

27 Nov 2024

Study: One in five young Spaniards spends over two hours daily on TikTok

One in five young Spaniards spends more than two hours a day on TikTok and exceeds the recommended limits for the use of social media, which may lead to an increase in their likelihood of experiencing mental health problems.

27 Nov 2024

Dopamine and serotonin balance reward learning in opposing ways

If you've heard of two of the brain's chemical neurotransmitters, it's probably dopamine and serotonin. Never mind that glutamate and GABA do most of the work - it's the thrill of dopamine as the "pleasure chemical" and serotonin as tender mood-stabilizer that attract all the headlines.

25 Nov 2024

Study highlights barriers to long-term recovery for opioid use disorder patients

A new study led by Thomas Jefferson University researchers highlights critical healthcare gaps that hinder long-term recovery for people living with opioid use disorders (OUD) in Philadelphia.

25 Nov 2024

Researchers develop new approach to effectively deliver therapeutics into the brain

Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach - demonstrated in mouse models and isolated human brain tissue - to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases.

25 Nov 2024

Could medical imaging innovation be the catalyst for precision medicine?

Precision medicine leverages genetic and lifestyle data to customize treatments, enhancing healthcare efficiency and patient outcomes in disease management.

24 Nov 2024

New oral peptide therapy offers hope for chronic abdominal pain

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain.

22 Nov 2024

Study: One in five ex-smokers currently vape in England

About one in five people who have stopped smoking for more than a year in England currently vape, equivalent to 2.2 million people, according to a new study led by UCL (University College London) researchers.

21 Nov 2024

Social media reshapes children’s diets and body image with alarming consequences

Systematic review highlights the pervasive negative influence of social media on children’s dietary habits, emphasizing increased unhealthy food consumption, body dissatisfaction, and disordered eating behaviors.

19 Nov 2024

Small Solutions for Big Problems in Drug Discovery and Delivery

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief solutions at ELRIG Drug Discovery 2024.

19 Nov 2024

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with mixed results from clinical trials.

19 Nov 2024

BU School of Medicine receives grant to expand education on opioid use disorder treatment

The Boston University Chobanian & Avedisian School of Medicine Center for Continuing Education (BU CCE) recently received a two-year, $400,000 grant from the Massachusetts Board of Registration in Medicine to create continuing education programs to increase the number of physicians and advanced practice providers that incorporate treatment for opioid use disorders (OUD) into their primary care practices.

19 Nov 2024

Addiction News and Research

KFF Health News' 'What the Health?': A colorful cast could lead key health agencies

Discovery of leptin-responsive neurons offers new hope for obesity treatment

Dual use of vapes and cigarettes hinders smoking cessation

Baycrest study discovers role of thalamus in post-stroke recovery

California falling short of enrollment goal as mental health courts roll out statewide

Boosting endocannabinoids could reduce opioid addiction risk

Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication

Telemedicine and peer support show promise in treating hepatitis C in rural areas

IQWiG evaluates smoking cessation drugs for severe tobacco dependence treatment

Study: One in five young Spaniards spends over two hours daily on TikTok

Dopamine and serotonin balance reward learning in opposing ways

Study highlights barriers to long-term recovery for opioid use disorder patients

Researchers develop new approach to effectively deliver therapeutics into the brain

Could medical imaging innovation be the catalyst for precision medicine?

New oral peptide therapy offers hope for chronic abdominal pain

Study: One in five ex-smokers currently vape in England

Social media reshapes children’s diets and body image with alarming consequences

Small Solutions for Big Problems in Drug Discovery and Delivery

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

BU School of Medicine receives grant to expand education on opioid use disorder treatment

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News